Eisai
4523.T
#1949
Rank
C$12.23 B
Marketcap
$43.27
Share price
-0.30%
Change (1 day)
-32.18%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

Earnings for Eisai (4523.T)

Earnings in 2024 (TTM): C$0.58 Billion

According to Eisai's latest financial reports the company's current earnings are C$5.06 Billion. In 2023 the company made an earning of C$0.76 Billion, an increase over its 2022 earnings that were of -C$33.2 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Eisai from 2009 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) C$0.58 B-23.09%
2023 C$0.76 B-2392.87%
2022 -C$33.2 Million-103.6%
2021 C$0.92 B-39.52%
2020 C$1.52 B7.3%
2019 C$1.42 B17.23%
2018 C$1.21 B86.06%
2017 C$0.65 B-23.64%
2016 C$0.85 B27.28%
2015 C$0.67 B22.08%
2014 C$0.54 B-46.11%
2013 C$1.01 B-21.67%
2012 C$1.30 B-20.72%
2011 C$1.64 B-8.44%
2010 C$1.79 B18.85%
2009 C$1.50 B